[1] Yang L, Wu T, Li J, et al. Artificial liver treatment improves survival in patients with hepatitis B virus-related acute-on-chronic liver failure: a case-control matched analysis. Hepatol Res, 2020,50(6):656-670. [2] Spagnuolo MS, Bergamo P, Crescenzo R, et al. Brain Nrf2 pathway, autophagy, and synaptic function proteins are modulated by a short-term fructose feeding in young and adult rats. Nutr Neurosci, 2020,23(4):309-320. [3] Yan Q, Wang L, Lai L, et al. Next generation sequencing reveals novel alterations in B-cell heavy chain receptor repertoires associated with acute-on-chronic liver failure. Int J Mol Med, 2019,43(1):243-255. [4] 赵洁,李力,李秀惠, 等.乙型肝炎病毒相关慢加急性肝衰竭患者短期预后模型的建立及预测价值研究. 中华危重病急救医学, 2020,32(8):988-993. [5] Enoch DA, Yang H, Aliyu SH, et al. The changing epidemiology of invasive fungal infections. Methods Mol Biol, 2017,1508:17-65. [6] Pagano L, Busca A, Candoni A, et al. Risk stratification for invasive fungal infections in patients with hematological malignancies: seifem recommendations. Blood Rev. 2017,31(2):17-29. [7] Verma N, Singh S, Taneja S, et al. Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections. Liver Int, 2019,39(3):503-513. [8] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版). 实用肝脏病杂志, 2019,22(2):164-171. [9] 中华医学会重症医学分会.重症患者侵袭性真菌感染诊断与治疗指南(2007年). 中华内科杂志, 2007,46(11):960-966. [10] Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into meld. Gastroenterology, 2006,130(6):1652-60. [11] Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001,33(2):464-470. [12] Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology, 2013,144(7):1426-1437. [13] 中华医学会肝病学分会.肝硬化肝性脑病诊疗指南. 中华内科杂志, 2018,57(10):705-718. [14] Zhang X, Yang M, Hu J, et al. Epidemiology of invasive pulmonary aspergillosis in patients with liver failure: clinical presentation, risk factors, and outcomes. J Int Med Res, 2018,46(2):819-827. [15] Wu T, Li J, Shao L, et al. Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure. Gut, 2018,67(12):2181-2191. [16] 应高翔,杨英,吴凤天,等.慢加急性肝衰竭患者并发感染的特点及对诊断的影响. 中华临床感染病杂志, 2020,13(2):140-148. [17] Lin S, Zhang K, Zhang J, et al. Long-term outcomes of patients with hepatitis B virus-related acute on chronic liver failure: An observational cohort study. Liver Int, 2019,39(5):854-860. [18] 姚运海,赵卫峰,甘建和.终末期肝病模型联合动脉血乳酸对乙型肝炎病毒相关慢加急性肝衰竭预后的评价:97例患者的回顾性分析. 中华肝脏病杂志, 2019,27(4):256-260. [19] Shen G, Sun S, Huang J, et al. Dynamic changes ofT cell receptor repertoires in patients with hepatitis B virus-related acute-on-chronic liver failure. Hepatol Int, 2020,14(1):47-56. [20] Xie Z, Violetta L, Chen E, et al. A prognostic model for hepatitis B acute-on-chronic liver failure patients treated using a plasma exchange-centered liver support system. J Clin Apher, 2020,35(2):94-103. |